scholarly journals Effects of N-Substituents on the Functional Activities of Naltrindole Derivatives for the δ Opioid Receptor: Synthesis and Evaluation of Sulfonamide Derivatives

Molecules ◽  
2020 ◽  
Vol 25 (17) ◽  
pp. 3792
Author(s):  
Chiharu Iwamatsu ◽  
Daichi Hayakawa ◽  
Tomomi Kono ◽  
Ayaka Honjo ◽  
Saki Ishizaki ◽  
...  

We have recently reported that N-alkyl and N-acyl naltrindole (NTI) derivatives showed activities for the δ opioid receptor (DOR) ranging widely from full inverse agonists to full agonists. We newly designed sulfonamide-type NTI derivatives in order to investigate the effects of the N-substituent on the functional activities because the side chain and S=O part in the sulfonamide moiety located in spatially different positions compared with those in the alkylamine and amide moieties. Among the tested compounds, cyclopropylsulfonamide 9f (SYK-839) was the most potent full inverse agonist for the DOR, whereas phenethylsulfonamide 9e (SYK-901) showed full DOR agonist activity with moderate potency. These NTI derivatives are expected to be useful compounds for investigation of the molecular mechanism inducing these functional activities.

2020 ◽  
Vol 20 (31) ◽  
pp. 2889-2902 ◽  
Author(s):  
Shigeto Hirayama ◽  
Hideaki Fujii

The discovery of δ opioid receptor inverse agonist activity induced by ICI-174,864, which was previously reported as an δ opioid receptor antagonist, opened the door for the investigation of inverse agonism/constitutive activity of the receptors. Various peptidic or non-peptidic δ opioid receptor inverse agonists have since been developed. Compared with the reports dealing with in vitro inverse agonist activities of novel compounds or known compounds as antagonists, there have been almost no publications describing the in vivo pharmacological effects induced by a δ opioid receptor inverse agonist. After the observation of anorectic effects with the δ opioid receptor antagonism was discussed in the early 2000s, the short-term memory improving effects and antitussive effects have been very recently reported as possible pharmacological effects induced by a δ opioid receptor inverse agonist. In this review, we will survey the developed δ opioid receptor inverse agonists and summarize the possible in vivo pharmacological effects by δ opioid receptor inverse agonists. Moreover, we will discuss important issues involved in the investigation of the in vivo pharmacological effects produced by a δ opioid receptor inverse agonist.


2019 ◽  
Vol 10 (9) ◽  
pp. 3939-3945 ◽  
Author(s):  
Eika Higashi ◽  
Shigeto Hirayama ◽  
Jun Nikaido ◽  
Marie Shibasaki ◽  
Tomomi Kono ◽  
...  

1999 ◽  
Vol 380 (1) ◽  
pp. R9-R10 ◽  
Author(s):  
Keiko Hosohata ◽  
Thomas H Burkey ◽  
Josua Alfaro-Lopez ◽  
Victor J Hruby ◽  
William R Roeske ◽  
...  

2005 ◽  
Vol 22 (8) ◽  
pp. 2106-2110 ◽  
Author(s):  
Leyre Urigüen ◽  
Fernando Berrendero ◽  
Catherine Ledent ◽  
Rafael Maldonado ◽  
Jorge Manzanares

Molecules ◽  
2018 ◽  
Vol 23 (12) ◽  
pp. 3181 ◽  
Author(s):  
Nannan Sun ◽  
Congmin Yuan ◽  
Xiaojun Ma ◽  
Yonghui Wang ◽  
Xianfeng Gu ◽  
...  

As an attractive drug-target, retinoic acid receptor-related orphan receptor-gamma-t (RORγt) has been employed widely to develop clinically relevant small molecular modulators as potent therapy for autoimmune disease and cancer, but its molecular mechanism of action (MOA) remains unclear. In the present study, we designed and discovered two novel RORγt ligands that are similar in structure, but different in efficacy. Using fluorescence resonance energy transfer (FRET) assay, compound 1 was identified as an agonist with an EC50 of 3.7 μM (max. act.: 78%), while compound 2 as an inverse agonist with an IC50 value of 2.0 μM (max. inh.: 61%). We performed molecular dynamics (MD) simulations, and elucidated the MOA of RORγt agonist and inverse agonist. Through the analyses of our MD results, we found that, after RORγt is bound with the agonist 1, the side chain of Trp317 stays in the gauche- conformation, and thus helps to form the hydrogen bond, His479-Trp502, and a large hydrophobic network among H11, H11′, and H12. All these interactions stabilize the H12, and helps the receptor recruit the coactivator. When the RORγt is bound with the inverse agonist 2, the side chain of Trp317 is forced to adopt the trans conformation, and these presumed interactions are partially destroyed. Taken together, the critical role of residue Trp317 could be viewed as the driving force for the activation of RORγt.


2015 ◽  
Vol 25 (15) ◽  
pp. 2927-2930 ◽  
Author(s):  
Toru Nemoto ◽  
Yusuke Iihara ◽  
Shigeto Hirayama ◽  
Takashi Iwai ◽  
Eika Higashi ◽  
...  

Author(s):  
Rei Mishima ◽  
Takashi Iwai ◽  
Shigeto Hirayama ◽  
Misa Oyama ◽  
Shun Watanabe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document